Studies of CRISPR/Cas9-mediated somatic genome editing of Pten in wild-type mice also demonstrated that Pten loss led to increased Akt phosphorylation and hepatic steatosis in hepatocytes at 4 months’ post treatment22, 38. This evidence concerns the gene PTEN and steatosis.